A detailed history of Core Cap Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Core Cap Advisors, LLC holds 700 shares of AMRN stock, worth $371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$371
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.57 - $0.8 $398 - $560
700 New
700 $0
Q1 2024

Aug 08, 2024

BUY
$0.82 - $1.35 $574 - $945
700 New
700 $0
Q4 2022

Feb 10, 2023

BUY
$1.07 - $1.34 $802 - $1,005
750 New
750 $0
Q2 2022

Aug 11, 2022

BUY
$1.13 - $3.69 $1,130 - $3,690
1,000 New
1,000 $1,000
Q1 2022

Apr 29, 2022

SELL
$2.85 - $3.73 $2,850 - $3,730
-1,000 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$3.24 - $5.18 $3,240 - $5,180
1,000 New
1,000 $3,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.